Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, Taiwan.

Journal of the Chinese Medical Association : JCMA - 1 Mar 2021

Jang Tyng-Yuan, Liang Po-Cheng, Liu Ta-Wei, Wei Yu-Ju, Yeh Ming-Lun, Hsu Cheng-Ting, Hsu Po-Yao, Lin Yi-Hung, Hsieh Meng-Hsuan, Huang Ching-I, Huang Chung-Feng, Lin Zu-Yau, Chen Shinn-Cherng, Huang Jee-Fu, Dai Chia-Yen, Yu Ming-Lung, Chuang Wan-Long

Abstract excerpt

BACKGROUND: The World Health Organization (WHO) set out to eliminate hepatitis C virus (HCV) infection by 2030, a goal Taiwan might achieve before 2025. Using effective direct antiviral agents (DAAs) against chronic hepatitis C (CHC) in Taiwan, the treatment of CHC has been initiated in rural areas. Here, we aimed to elucidate the clinical and virological characteristics of HCV infection, and the treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Antiviral Agents

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Taiwan

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 33433134
DOI: 10.1097/JCMA.0000000000000478
PMCID: PMC12966053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, Taiwan.PMID 33433134Read ↗

The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study.Semantic proximity Read ↗

Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6.Semantic proximity Read ↗

Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution.Semantic proximity Read ↗

Epidemiological characteristics, genotype patterns, and treatment outcomes in chronic hepatitis C patients receiving direct-acting antivirals: a cohort study from Istanbul, Türkiye.Semantic proximity Read ↗

Geographic Variation of Indigenous Hepatitis C Virus Subtypes 6g and 6w in an Endemic Area of Southern TaiwanSemantic proximity Read ↗

Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients' characteristics and clinical parameters.Semantic proximity Read ↗

Daclatasvir plus sofosbuvir, with or without ribavirin, is highly effective for all kinds of genotype-2 chronic hepatitis-C infection in Taiwan.Semantic proximity Read ↗

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China.Semantic proximity Read ↗

Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011.Semantic proximity Read ↗

The nationwide distribution and trends of hepatitis C virus genotypes in mainland China.Semantic proximity Read ↗

Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.